# A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome

> **NCT07406932** · NA · NOT_YET_RECRUITING · sponsor: **China-Japan Friendship Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Antisynthetase Syndrome
- Interstitial Lung Disease (ILD)

## Interventions

- **DRUG:** JAK Inhibitor
- **DRUG:** Calcineurin Inhibitors (CNI)

## Key facts

- **NCT ID:** NCT07406932
- **Lead sponsor:** China-Japan Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07406932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07406932, "A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07406932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*